Assessing the Efficacy and Safety of Three Different Regimens of Etanercept (ETN) 50mg Twice a Week, Combination of ETN 25mg and Acitretin, and Acitretin Alone in Korean Psoriasis Patients.
Phase of Trial: Phase IV
Latest Information Update: 06 Apr 2012
At a glance
- Drugs Acitretin; Etanercept
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Wyeth
- 13 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 31 Aug 2010 Planned end date changed from 1 Oct 2010 to 1 Jun 2011 as reported by ClinicalTrials.gov.